Brief: ALK Abello: Torii Pharmaceutical reports positive trial results for Japanese Cedar SLIT-tablet

Torii Pharmaceutical Co

07/08/2015 08:00

Aug 7 (Reuters) - ALK Abello A/S  ALKb.CO : 
    * Announced partner for Japan, Torii Pharmaceutical Co., 
Ltd.  4551.T   has reported positive results from its Phase 
II/III trial into a sublingual allergy immunotherapy tablet 
(SLIT-tablet) for Japanese cedar tree pollen allergic rhinitis 
(hay fever) 
    * Torii will now proceed with the preparations for a 
submission of a New Drug Application to the Japanese Ministry of 
Health, Labour and Welfare 
 
Source text for Eikon:  ID:nCSE5Xlz  
     
Further company coverage:  ALKb.CO  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48586983920;))